2-BROMO-5,6-DICHLORO-1-(2,3,5-TRI-O-ACETYL-.ALPHA.-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE
UNII YM2EC2HXD5
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-bromo-5,6-dichloro-1-(2,3,5-tri-o-acetyl-.alpha.-l-ribofuranosyl)-1h-benzimidazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YM2EC2HXD5.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 176161-21-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H17BrCl2N2O7 YOHBOWGRGQAKAT-LUKYLMHMSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-bromo-5,6-dichloro-1-(2,3,5-tri-o-acetyl-.alpha.-l-ribofuranosyl)-1h-benzimidazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.